According to a recent press release, Janssen recently submitted a Biologics License Application (BLA) to the FDA for talquetamab to treat relapsed or refractory multiple myeloma. The CDC states that...
Data from the CDC suggests that, as of 2018, approximately 20.4% of adults in the United States were living with chronic pain. Additionally, 8% of US adults had high-impact chronic pain. Pain management is essential in healthcare, as...
According to the CDC, 20% of children and adolescents in the United States deal with pediatric obesity. Obesity is linked with high blood pressure, high cholesterol, type 2 diabetes, joint problems,...
Biosimilars, biologic products similar to brand-name biologics, are praised as a less expensive alternative for patients with chronic diseases requiring biologics. Many providers and healthcare experts...
Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation due to their condition. To manage...
In a recent press release from Eli Lilly and Company, the company announced that it had completed the acquisition of Akouos. Earlier this year, on October 18, 2022, Lilly announced plans to acquire the...
In a Drug Safety Communication issued on November 22, 2022, the FDA announced that it is investigating Prolia and its associations with severe hypocalcemia — low blood calcium levels — in...
On October 12, 2022, the FDA announced a shortage of Adderall and Adderall IR. These shortages have exacerbated withdrawal symptoms and left patients struggling to manage their ADHD by rationing their medication. Understanding how...
Amyotrophic lateral sclerosis, ALS, is a life-threatening neurodegenerative disease that can lead to paralysis and death. Over 5,000 individuals in the United States are diagnosed with ALS each year,...
A recent analysis by Vantage Market Research found that in 2021 the global biosimilars market was valued at $28.46 billion. Projections based on market trajectory predict that the market will surpass $103.94 billion by 2028. While...
According to the CDC, of all people with diabetes, up to 10% have type 1 diabetes (T1D), sometimes referred to as juvenile or insulin-dependent diabetes. This type of diabetes typically develops early...
AstraZeneca and Avillion recently teamed up to develop PT027, an asthma rescue inhaler. PT027 is a pressurized metered-dose inhaler that delivers a fixed dose of two combined asthma medications,...
In a recent press release, GoodRx, a digital healthcare platform, launched Provider Mode. Provider Mode is a new experience that is specifically targeted to healthcare professionals (HCPs). PharmaNewsIntelligence interviewed Preeti Parikh,...
In a recent press release, Cynata Therapeutics, a biotechnology company, announced a partnership with Leiden University Medical Center (LUMC) to explore how mesenchymal stem cells may reduce the need...
According to an announcement by the NHS, the first humans have been transfused with lab-grown red blood cells as part of the RESTORE trial. The RESTORE trial is a randomized clinical trial in which red...
According to the Mayo Clinic, IgA nephropathy — sometimes referred to as Berger’s disease — is an autoimmune disease in which an antibody called immunoglobulin A (IgA) builds up in the kidneys, leading to local...
The financial burden associated with cancer treatment and recovery is significant. Many patients struggle to obtain medicines and continued care. According to a recent study published in JAMA Network...
In recent years — especially considering the COVID-19 pandemic — the public has become increasingly aware of pharmacists’ role in healthcare. Despite the current prevalence of clinical pharmacists and their position on...
As the rate of chronic disease in the United States continues to rise, industry members are looking for new and effective methods to manage and treat these disorders. The Pharmaceutical Research and...
On October 3, 2022, the FDA awarded the Biologics and Biosimilars Collective Intelligence (BBIC) a $1.3 million grant to be paid out in the next two years. The grant is intended to fund a study on...
